Source: India Infoline

Symed labs: Sued by Symed Labs and Hetero! Glenmark Pharma at day's low

The companies allege that Glenmark is preparing to sell the crystalline form, or form-III, of linezolid and carry out processes to manufacture the product before the patents on it expire, report added.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
CEO Avatar

Managing Director

Mohan Rao

CEO Approval Rating

90/100

Read more